Send Inquiry

Request To Call Back

Gleevec Imatinib Drug

Name: Gleevec Imatinib Drug
Brand: BHAVYA ENTERPRISES
Price: 1500 INR
Availability: InStock

Price 1500 INR/ Pack

Get a Price/Quote

MOQ : 100 Packs

Gleevec Imatinib Drug Specification

Pacakaging (Quantity Per Box)
10 Tablets

Indication
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia

Dosage Form
Tablet

Origin of Medicine
India

Salt Composition
Imatinib 400 mg

Brand Name
Gleevec

Packaging Type
Box

Life Span
24 Months

Drug Type
Allopathic

Ingredients
Imatinib Mesylate

Physical Form
Tablet

Function
Anti-cancer, inhibits BCR-ABL

Recommended For
Adults with CML/ALL

Dosage
400 mg once daily or as directed

Dosage Guidelines
Take with meal and water

Suitable For
Adults

Quantity
10 Tablets

Storage Instructions
Store below 30C, dry place

Mfg License
With valid GMP

Administration Route
Oral use

Patient Category
Oncology

Tablet Shape
Oval

Coating
Film-coated

Manufacturer Country
India

Color
Red & white

Prescription Only
Yes

Allergen Info
Lactose containing

Marketed By
Novartis

Gleevec Imatinib Drug Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Gleevec Imatinib Drug

Experience the distinguished power of Gleevec Imatinib, a hot-selling oncology solution, now available at an astonishing price cut! Designed for adults battling Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL), this lavish red and white, oval-shaped, film-coated tablet comes in a box of 10. Manufactured in India under strict GMP standards by Novartis, Gleevec contains Imatinib Mesylate and is recommended at 400 mg once daily or as prescribed. Please note, this product is prescription only and contains lactose. Seize the sale while stocks last!

Distinguished Features & Commercial Applications

Gleevec Imatinib shines with its lavish anti-cancer efficacy, finely crafted oval tablets, and precise dosage for oncology care. Not just a hot-seller in hospitals and clinics, this film-coated product inhibits BCR-ABL for effective cancer management. Packaged securely in boxes of 10 for commercial use, it is ideally suited for adults diagnosed with CML or ALL, elevating industry standards with its pharmaceutical excellence and reliability.

Domestic Market, Certifications & Order Fulfillment

Focusing on India's main domestic market, Gleevec Imatinib upholds certifications like GMP for trusted safety. Packaging is designed for easy delivery and drop-off, ensuring products remain secure from order completion to customer handover. Each order comes in a sealed box containing 10 tablets, reaching users swiftly and efficiently by reliable suppliers and traders across the country.

FAQ's of Gleevec Imatinib Drug:

Q: How should Gleevec Imatinib be administered for optimal results?

A: Gleevec Imatinib should be taken orally once daily, preferably with a meal and a glass of water, following your doctor's dosage instructions for best outcomes.

Q: What main conditions does Gleevec Imatinib treat?

A: This distinguished tablet is primarily indicated for the treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults.

Q: When does the product expire and how should it be stored?

A: Gleevec has a lifespan of 24 months. Store below 30C in a dry place, and always keep it in its original packaging to preserve efficacy.

Q: Where is Gleevec Imatinib manufactured and marketed?

A: Gleevec is manufactured in India, ensuring compliance with GMP standards, and is marketed by Novartis for oncology patients.

Q: What are the commercial uses of the Gleevec Imatinib tablet?

A: Gleevec is supplied to hospitals, clinics, and oncology centers for the anti-cancer management of adult patients diagnosed with CML or ALL.

Q: How does Gleevec function as an anti-cancer drug?

A: Gleevec inhibits the BCR-ABL tyrosine kinase, which is crucial for the progression of certain cancers, making it a lavishly effective choice in oncology.

Tell us about your requirement